Enclomiphene
Also known as: trans-clomiphene, Enclomiphene citrate, Androxal
Classification
Serm
Regulatory Status
n/a
Sources
2
Review
n/a
Overview
Enclomiphene is the trans-isomer of clomiphene and a SERM that stimulates endogenous gonadotropin release, studied for raising testosterone while aiming to preserve spermatogenesis compared with exogenous testosterone in secondary hypogonadism research.
Evidence and limitations
Human/preclinical evidence breakdown is not available in this record.
Pathways
Interactions & cautions
Flagged in source data
Drug interactions
exogenous testosterone therapy — Combining can obscure response and fertility goals. (review)
other SERMs (e.g., clomiphene, tamoxifen) — Redundant endocrine effects and stacked risk. (review)
These are observational flags for review, not individualized instructions.
Sources
Educational reference only — not medical advice.
What people report (anecdote)
CLINICAL DATA (from trials)
Adverse events:
None recorded in our sources.
Effects measured:
Human trials: none found.
ANECDOTE
What people report: anecdote, not evidence
Loading…
Submit a claim you saw